248
Views
0
CrossRef citations to date
0
Altmetric
Assessment Procedures

Validation of Moorong Self-Efficacy Scale among Chinese stroke survivors

ORCID Icon, , , , , , , , , & show all
Pages 3151-3155 | Received 22 Feb 2023, Accepted 24 Jul 2023, Published online: 09 Aug 2023
 

Abstract

Purpose

To examine the psychometric properties of a Chinese version of the Moorong Self-Efficacy Scale (MSES-C) among stroke survivors.

Methods

A cross-sectional descriptive study was conducted with 160 stroke survivors recruited from the three neurology departments in China. Reliability, concurrent validity, and construct validity of the scale were determined.

Results

The MSES-C whole scale showed good internal consistency with a Cronbach’s α of 0.953. There was a moderate to a strong positive correlation between the MSES-C and Chinese version of the General Self-Efficacy Scale (r = 0.695, p < 0.000), a strong positive correlation between the MSES-C and Chinese version of the stroke specific self-efficacy scale (r = 0.801, p < 0.000), positive correlations between the MSES-C and Chinese versions of the Modified Barthel Index (r = 0.695, p < 0.000), and a negative correlation between the MSES-C and National Institutes of Health Stroke Scale (r = –0.511, p < 0.000). Known-group validity was also supported.

Conclusions

The MSES-C is a reliable and valid instrument for assessing self-efficacy in Chinese stroke survivors.

IMPLICATIONS FOR REHABILITATION

  • The Chinese version of the Moorong Self-Efficacy Scale demonstrated good internal consistency and showed satisfactory concurrent and construct validity among stroke survivors.

  • The Moorong Self-Efficacy Scale can be used to assess stroke recovery among the Chinese population in clinical and research settings.

Disclosure statement

None.

Additional information

Funding

This work was supported by Yunnan Philosophy and Social Science Planning Popular Science Project [SKPJ202151].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.